Thursday, October 15, 2015

Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells

Nanoscale, 2015, Advance Article
DOI: 10.1039/C5NR04867B, Communication
Qingxin Mu, Forrest M. Kievit, Rajeev J. Kant, Guanyou Lin, Mike Jeon, Miqin Zhang
A small, uniform, stable and biocompatible theranostic nanoparticle was developed for active targeting of HER2/neu positive human breast cancer and improvement of cancer cell killing.
To cite this article before page numbers are assigned, use the DOI form of citation above.
The content of this RSS Feed (c) The Royal Society of Chemistry


Click for full article

No comments:

Post a Comment